Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FWEYE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,483
Award facts
- Contract value 100% obligated
- $16,483.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on October 23, 2025, with an ultimate completion date of October 24, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and supply the oncology medication to support Department of Defense medical supply needs.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to provide comprehensive pharmaceutical support to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499.999 billion, was awarded on November 13, 2025, and authorizes the issuance of delivery orders for branded and generic prescription drugs, biologics, and medical consumables through December 31, 2036. DMS Pharmaceutical Group's established performance across numerous delivery orders positions it as a critical supplier within the federal pharmaceutical supply chain for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FWEYE?
SPE2DB26FWEYE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FWEYE worth?
The government has obligated $16,483 on SPE2DB26FWEYE.
Is contract SPE2DB26FWEYE an order under another contract?
Yes. SPE2DB26FWEYE is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB26FWEYE competed?
The extent of competition for SPE2DB26FWEYE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award